Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
NVRO

NVRO - Nevro Corp Stock Price, Fair Value and News

$0.140.00 (0.00%)
Market Closed

82/100

NVRO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

82/100

NVRO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$0.2

Target 3M

$0.16

Target 6M

$0.18

NVRO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NVRO Price Action

Last 7 days

7.7%

Last 30 days

16.7%

Trailing 12 Months

55.6%

NVRO RSI Chart

NVRO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NVRO Valuation

Market Cap

3.8M

Price/Earnings (Trailing)

-0.03

Price/Sales (Trailing)

0.01

EV/EBITDA

-1.04

Price/Free Cashflow

-0.12

NVRO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$0.2

Target 3M

$0.16

Target 6M

$0.18

NVRO Fundamentals

NVRO Revenue

NVRO Earnings

NVRO Profitability

Free Cashflow Yield

-857.27%

NVRO Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024430.7M426.1M419.1M408.5M
2023414.9M419.4M422.8M425.2M
2022386.1M388.0M395.3M406.4M
2021363.2M409.1M393.9M386.9M
2020395.6M358.4M366.7M362.0M
2019381.8M379.3M383.8M390.3M
2018345.9M363.9M377.3M387.3M
2017255.3M277.9M299.2M326.7M
2016101.6M145.6M191.1M228.5M
201535.6M39.5M46.2M69.6M
201424.8M26.6M29.1M32.6M
201319.5M20.8M22.2M23.5M
201200018.1M
Get all data in R, Python etc through our Historical Stock Data APIs

About Nevro Corp

NVRO
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation system for the treatment of chronic pain, as well as Senza II and Senza Omnia SCS systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company's Senza HFX iQ IPG system includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system. In addition, it offers surpass surgical and percutaneous leads. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
 CEO
 WEBSITEhttps://nevro.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES1087

Nevro Corp Frequently Asked Questions

NVRO is the stock ticker symbol of Nevro Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Nevro Corp is 3.79 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check NVRO's fair value in chart for subscribers.

The fair value guage provides a quick view whether NVRO is over valued or under valued. Whether Nevro Corp is cheap or expensive depends on the assumptions which impact Nevro Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NVRO.

As of Wed Jan 28 2026, NVRO's PE ratio (Price to Earnings) is -0.03 and Price to Sales (PS) ratio is 0.01. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NVRO PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Nevro Corp has provided -0.456 (multiply by 100 for percentage) rate of return.